Showing results (491-500 of 559) with videos related to
Sort By:
Pageof 56
The New England Journal of Medicine|September 16, 2011
Response-guided telaprevir combination treatment for hepatitis C virus infectionKenneth E Sherman, Steven L Flamm, Nezam H Afdhal, et al.Journal of Hepatology|April 4, 2020
DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohortElizabeth C Verna, Giuseppe Morelli, Norah A Terrault, et al.Nature Communications|October 13, 2023
Characterization of the horse chestnut genome reveals the evolution of aescin and aesculin biosynthesisWei Sun, Qinggang Yin, Huihua Wan, et al.Plos Genetics|February 5, 2019
Genomic insights into neonicotinoid sensitivity in the solitary bee Osmia bicornisKatherine Beadle, Kumar Saurabh Singh, Bartlomiej J Troczka, et al.Open Forum Infectious Diseases|August 28, 2025
Development and Validation of a Machine Learning-Based Screening Algorithm to Predict High-Risk Hepatitis C InfectionSuk-Chan Jang, Wei-Hsuan Lo-Ciganic, Pilar Hernandez-Con, et al.Journal of Hepatology|May 17, 2019
Patient-reported symptoms during and after direct-acting antiviral therapies for chronic hepatitis C: The PROP UP studyDonna M Evon, Souvik Sarkar, Jipcy Amador, et al.Gut|July 16, 2016
Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET studyTania M Welzel, David R Nelson, Giuseppe Morelli, et al.Gastroenterology|July 6, 2010
Albinterferon Alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic hepatitis C virus genotype 2 or 3David R Nelson, Yves Benhamou, Wan-Long Chuang, et al.Liver International : Official Journal of the International Association for the Study of the Liver|January 2, 2021
Patient-reported outcomes 12 months after hepatitis C treatment with direct-acting antivirals: Results from the PROP UP studyMarina Serper, Donna M Evon, Jipcy Amador, et al.Gastroenterology|August 28, 2016
Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated With Sustained Virologic ResponseNorah A Terrault, Stefan Zeuzem, Adrian M Di Bisceglie, et al.Pageof 56